Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
Patent Number 11571465 - February 7, 2023
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the…
Thymosin alpha 1 for use in treatment of cystic fibrosis
Patent Number 11524056 - December 13, 2022
The present invention concerns Thymosin alpha 1 (T?1) for use in treatment of cystic fibrosis as a CFTR corrector, CFTR potentiator and…
Thymosin alpha 1 for use in treatment of cystic fibrosis
Patent Number 10478474 - November 19, 2019
The present invention concerns Thymosin alpha 1 for use in treatment of cystic fibrosis as a CFTR corrector, CFTR potentiator and…
Treatment of cancer with immune stimulators
Patent Number 9724395 - August 8, 2017
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the…
Alpha thymosin peptides as vaccine enhancers
Patent Number 8716012 - May 6, 2014
The present invention provides methods of vaccination as well as pharmaceutical combinations and kits for enhancing vaccine effectiveness,…
TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES
Application Number 20120295840 - November 22, 2012
A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The…
PREVENTION OR DELAY OF ONSET OF ORAL MUCOSITIS
Application Number 20110245316 - October 6, 2011
The present invention provides a method for preventing or delaying the onset of oral mucositis, including the onset of ulcerative or severe…
Treatment or Prevention of Hepatitis C with Immunomodulator Compounds
Application Number 20110200558 - August 18, 2011
A method of treatment for treating or preventing hepatitis C (HepC) in a target subject, including administering to the target subject an…
Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa
Application Number 20110117211 - May 19, 2011
An immunomodulatory compound is utilized to treat mucosa disease.
TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)
Application Number 20100330093 - December 30, 2010
Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating…
Salpeter-Levy v. SciClone Pharmaceuticals, Inc. et al
California Northern District Court - August 29, 2017
Sciabacucchi v. SciClone Pharmaceuticals, Inc. et al
California Northern District Court - August 17, 2017
Consoli v. SciClone Pharmaceuticals, Inc. et al
California Northern District Court - August 16, 2017
Daley v. SciClone Pharmaceuticals, Inc. et al
California Northern District Court - August 9, 2017
Karner et al v. SciClone Pharmaceuticals, Inc. et al
California Northern District Court - September 7, 2010
"In re SciClone Pharmaceuticals Securities Litigation"
California Northern District Court - December 1, 2010
STIPULATION AND ORDER Granting Dismissal without Prejudice Pursuant to FRCP 41(a)(1) re 29 Stipulation. Signed by Judge James Ware on…
